Copyright Reports & Markets. All rights reserved.

Global Dermal Substitutes Market Research Report 2021

Request for Sample of this report
Buy now

1 Dermal Substitutes Market Overview

  • 1.1 Product Overview and Scope of Dermal Substitutes
  • 1.2 Dermal Substitutes Segment by Type
    • 1.2.1 Global Dermal Substitutes Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Synthetic
    • 1.2.3 Biosynthetic
    • 1.2.4 Biological
  • 1.3 Dermal Substitutes Segment by Application
    • 1.3.1 Dermal Substitutes Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Wound Care Centers
    • 1.3.4 Others
  • 1.4 Global Dermal Substitutes Market Size Estimates and Forecasts
    • 1.4.1 Global Dermal Substitutes Revenue 2016-2027
    • 1.4.2 Global Dermal Substitutes Sales 2016-2027
    • 1.4.3 Dermal Substitutes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Dermal Substitutes Market Competition by Manufacturers

  • 2.1 Global Dermal Substitutes Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Dermal Substitutes Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Dermal Substitutes Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Dermal Substitutes Manufacturing Sites, Area Served, Product Type
  • 2.5 Dermal Substitutes Market Competitive Situation and Trends
    • 2.5.1 Dermal Substitutes Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Dermal Substitutes Players Market Share by Revenue
    • 2.5.3 Global Dermal Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dermal Substitutes Retrospective Market Scenario by Region

  • 3.1 Global Dermal Substitutes Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Dermal Substitutes Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Dermal Substitutes Market Facts & Figures by Country
    • 3.3.1 North America Dermal Substitutes Sales by Country
    • 3.3.2 North America Dermal Substitutes Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Dermal Substitutes Market Facts & Figures by Country
    • 3.4.1 Europe Dermal Substitutes Sales by Country
    • 3.4.2 Europe Dermal Substitutes Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Dermal Substitutes Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Dermal Substitutes Sales by Region
    • 3.5.2 Asia Pacific Dermal Substitutes Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Dermal Substitutes Market Facts & Figures by Country
    • 3.6.1 Latin America Dermal Substitutes Sales by Country
    • 3.6.2 Latin America Dermal Substitutes Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Dermal Substitutes Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Dermal Substitutes Sales by Country
    • 3.7.2 Middle East and Africa Dermal Substitutes Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Dermal Substitutes Historic Market Analysis by Type

  • 4.1 Global Dermal Substitutes Sales Market Share by Type (2016-2021)
  • 4.2 Global Dermal Substitutes Revenue Market Share by Type (2016-2021)
  • 4.3 Global Dermal Substitutes Price by Type (2016-2021)

5 Global Dermal Substitutes Historic Market Analysis by Application

  • 5.1 Global Dermal Substitutes Sales Market Share by Application (2016-2021)
  • 5.2 Global Dermal Substitutes Revenue Market Share by Application (2016-2021)
  • 5.3 Global Dermal Substitutes Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Integra Life Sciences
    • 6.1.1 Integra Life Sciences Corporation Information
    • 6.1.2 Integra Life Sciences Description and Business Overview
    • 6.1.3 Integra Life Sciences Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Integra Life Sciences Product Portfolio
    • 6.1.5 Integra Life Sciences Recent Developments/Updates
  • 6.2 Smith and Nephew
    • 6.2.1 Smith and Nephew Corporation Information
    • 6.2.2 Smith and Nephew Description and Business Overview
    • 6.2.3 Smith and Nephew Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Smith and Nephew Product Portfolio
    • 6.2.5 Smith and Nephew Recent Developments/Updates
  • 6.3 Organogenesis
    • 6.3.1 Organogenesis Corporation Information
    • 6.3.2 Organogenesis Description and Business Overview
    • 6.3.3 Organogenesis Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Organogenesis Product Portfolio
    • 6.3.5 Organogenesis Recent Developments/Updates
  • 6.4 Yantai Zhenghai Bio-tech
    • 6.4.1 Yantai Zhenghai Bio-tech Corporation Information
    • 6.4.2 Yantai Zhenghai Bio-tech Description and Business Overview
    • 6.4.3 Yantai Zhenghai Bio-tech Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Yantai Zhenghai Bio-tech Product Portfolio
    • 6.4.5 Yantai Zhenghai Bio-tech Recent Developments/Updates
  • 6.5 Guanhao Biotech
    • 6.5.1 Guanhao Biotech Corporation Information
    • 6.5.2 Guanhao Biotech Description and Business Overview
    • 6.5.3 Guanhao Biotech Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Guanhao Biotech Product Portfolio
    • 6.5.5 Guanhao Biotech Recent Developments/Updates
  • 6.6 PermeaDerm
    • 6.6.1 PermeaDerm Corporation Information
    • 6.6.2 PermeaDerm Description and Business Overview
    • 6.6.3 PermeaDerm Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 PermeaDerm Product Portfolio
    • 6.6.5 PermeaDerm Recent Developments/Updates
  • 6.7 Mylan (Viatris)
    • 6.6.1 Mylan (Viatris) Corporation Information
    • 6.6.2 Mylan (Viatris) Description and Business Overview
    • 6.6.3 Mylan (Viatris) Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mylan (Viatris) Product Portfolio
    • 6.7.5 Mylan (Viatris) Recent Developments/Updates
  • 6.8 MiMedx
    • 6.8.1 MiMedx Corporation Information
    • 6.8.2 MiMedx Description and Business Overview
    • 6.8.3 MiMedx Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 MiMedx Product Portfolio
    • 6.8.5 MiMedx Recent Developments/Updates
  • 6.9 Tissue Regenix
    • 6.9.1 Tissue Regenix Corporation Information
    • 6.9.2 Tissue Regenix Description and Business Overview
    • 6.9.3 Tissue Regenix Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Tissue Regenix Product Portfolio
    • 6.9.5 Tissue Regenix Recent Developments/Updates
  • 6.10 Allergan
    • 6.10.1 Allergan Corporation Information
    • 6.10.2 Allergan Description and Business Overview
    • 6.10.3 Allergan Dermal Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Allergan Product Portfolio
    • 6.10.5 Allergan Recent Developments/Updates

7 Dermal Substitutes Manufacturing Cost Analysis

  • 7.1 Dermal Substitutes Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Dermal Substitutes
  • 7.4 Dermal Substitutes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Dermal Substitutes Distributors List
  • 8.3 Dermal Substitutes Customers

9 Dermal Substitutes Market Dynamics

  • 9.1 Dermal Substitutes Industry Trends
  • 9.2 Dermal Substitutes Growth Drivers
  • 9.3 Dermal Substitutes Market Challenges
  • 9.4 Dermal Substitutes Market Restraints

10 Global Market Forecast

  • 10.1 Dermal Substitutes Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Dermal Substitutes by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Dermal Substitutes by Type (2022-2027)
  • 10.2 Dermal Substitutes Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Dermal Substitutes by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Dermal Substitutes by Application (2022-2027)
  • 10.3 Dermal Substitutes Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Dermal Substitutes by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Dermal Substitutes by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Synthetic
    Biosynthetic
    Biological

    Segment by Application
    Hospitals
    Wound Care Centers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Integra Life Sciences
    Smith and Nephew
    Organogenesis
    Yantai Zhenghai Bio-tech
    Guanhao Biotech
    PermeaDerm
    Mylan (Viatris)
    MiMedx
    Tissue Regenix
    Allergan

    Buy now